📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials. (2017)

First Author: Vallières C

Attributed to: Development and commercial exploitation of a novel fungicide designed to combat resistance in agriculture funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.00459-17

PubMed Identifier: 28652237

Publication URI: http://europepmc.org/abstract/MED/28652237

Type: Journal Article/Review

Volume: 61

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 9

ISSN: 0066-4804